News

Payers are becoming more receptive to a different approach for paying for addiction treatment and recovery services, as evidenced by the formation of a new healthcare alliance that aims to redesign the structure and payment of these services.

If all consumers had a high understanding of how to navigate the healthcare system, health insurers could save billions of dollars a year. Here’s what you should do.

Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.

Here’s how healthcare can do more to help patients learn more about their health to better prepare them to participate in their own treatment.

Glucose monitoring technology could become the go-to management strategy in a few years. Here’s where we are and where we are going.

FDA okayed a first-of-its-kind treatment for hairy cell leukemia (HCL).

Here are 4 key ways healthcare executives can leverage community resources to strengthen the availability of tools that support recovery from opioid addiction.

Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.

NORC at the University of Chicago set out to understand more Americans’ experiences with surprise billing. You won’t believe what they found.

A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.

Onboarding new oncology patients can be a delicate process to help them prepare for their care journey. Here are the first steps.

Surprising findings from the largest study to date investigating the genetics of osteoporosis and fracture risk.

Plenty of M&A deals look great on paper but ultimately fall apart in the post-deal integration phase. Here are the biggest pitfalls healthcare executives and stakeholders on both sides of a deal need to consider when managing this critical phase of the process.

FDA recently approved 2 new treatments, heightening competition in the HIV-1 drug marketplace.

FDA cleared the first and only easy-to-swallow liquid drug to treat amyotrophic lateral sclerosis (ALS).

While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.

The latest lymphoma research continues to bring new hope for patents, families and care providers. In looking at such advances, here are four things to know.

Not all therapies work the same in every patient, but that’s not the biggest challenge in treating mental health. This is.

Successful hospitals share the strategies they have used to reduce readmissions.

The amount of data in healthcare is growing, but that’s not necessarily translating to improved patient outcomes. Here’s why.

A pharma maker is recalling one lot of an allergy medication because the bottles mistakenly contain this medication.

These six medical conditions often accompany COPD, and providers should heed them as warning signs.

Progress in treating chronic obstructive pulmonary disease (COPD) is stymied by many factors. Here are the most problematic.

FDA is warning that a deadly infection has been reported with a widely used class of diabetes drugs.

In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.